Healthcare Associations

Video of Bradley Hunter, the vice president for value-based care and core solutions at KLAS Research, explaining how the Best in KLAS rates for health informatics vendors are created.

How are the best in KLAS Health IT vendor rankings created?

KLAS conducts annual assessments of all types of healthcare information systems such as PACS, EMRs and cardiovascular information systems and ranks them. Bradley Hunter, the vice president for value-based care and core solutions at KLAS Research, explains the process of ranking.
 

Thumbnail

Overlapping concerns: 5 takeaways from a new study on CVD, CKD and type 2 diabetes among US adults

How common is it for patients to present with overlapping cardiac, renal and metabolic issues? A new analysis in JAMA Cardiology explored that very question.

Thumbnail

Missed opportunities: Many high-risk patients still not taking aspirin to prevent CVD

Aspirin is known to be an effective, affordable way to prevent cardiovascular disease.

PHOTO GALLERY: Cardiac technologies on display at HIMSS 2023

Click through a series of photos of cardiology-related technologies from the world's largest health IT conference.

Thumbnail

Cardiologists, cardiac surgeons support new bill that could limit Medicare cuts

More than 100 U.S. medical societies—including the ACC, ASNC and others—have united in support of a new bill that would make a long-term impact on Medicare payments.

Thumbnail

A simple way to help cardiologists communicate with patients

A new JAMA Internal Medicine study suggests that communication coaching for cardiologists may help improve patient interactions by encouraging questions and increasing empathy.

U.S. News & World Report children’s hospitals cardiology heart surgery

Children with autism face higher risk of diabetes, heart disease, dyslipidemia

Researchers examined data from 34 different studies, publishing their full systematic review and meta-analysis in JAMA Pediatrics.

Thumbnail

High costs limit the value of dapagliflozin, empagliflozin as heart failure treatments

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.